Not applicableStudy completedNCT00723333What this trial is testingBone Marrow Transplant Chart Review for RICWho this might be right forMyelofibrosis University of Utah 30
Testing effectiveness (Phase 2)UnknownNCT02836639What this trial is testingBEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's LymphomaWho this might be right forLymphoma, Non-Hodgkin Pusan National University Hospital 20
Not applicableLooking for participantsNCT06111612What this trial is testingIntensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary InvolvementWho this might be right forAcute Myeloid LeukemiaMyelodysplastic NeoplasmChronic Myelomonocytic Leukemia+2 more Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Early research (Phase 1)UnknownNCT05005299What this trial is testingVenetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell TransplantationWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2+3 more Melbourne Health 18
Early research (Phase 1)Study completedNCT00606437What this trial is testingTotal Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) TransplantsWho this might be right forLymphomaMyelomaLeukemia+4 more Duke University 40
Not applicableStudy completedNCT04808167What this trial is testingRemote Ischemic Conditioning in HSCTWho this might be right forHematopoietic Stem Cell Transplantations Children's Hospital Medical Center, Cincinnati 17
Early research (Phase 1)Study completedNCT00641030What this trial is testingClofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01613300What this trial is testingStudy of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B PatientsWho this might be right forB-Cell Lymphomas Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 33
Not applicableStudy completedNCT00445744What this trial is testingCyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+19 more Fred Hutchinson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT01807611What this trial is testingHaploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic MalignancyWho this might be right forLeukemiaLymphoma St. Jude Children's Research Hospital 82
Testing effectiveness (Phase 2)UnknownNCT03547830What this trial is testingPlerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD PatientsWho this might be right forChronic Granulomatous Disease Federal Research Institute of Pediatric Hematology, Oncology and Immunology 17
Testing effectiveness (Phase 2)Study completedNCT00599495What this trial is testingMatched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCTWho this might be right forMultiple Myeloma Universitätsklinikum Hamburg-Eppendorf 50
Testing effectiveness (Phase 2)UnknownNCT06468267What this trial is testingRIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.Who this might be right forPeripheral T Cell Lymphoma Xianmin Song, MD 50
Early research (Phase 1)Looking for participantsNCT05066412What this trial is testingProphylactic CD45RA-depleted DLI After Haploidentical Transplantation/RICWho this might be right forHematologic MalignancyHaplo-identical Stem Cell Transplantation University Hospital, Geneva 12
Testing effectiveness (Phase 2)Study completedNCT03406962What this trial is testingMGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)Who this might be right forInherited Metabolic Disorders (IMD) Magenta Therapeutics, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT03263559What this trial is testingHaploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)Who this might be right forSickle Cell Disease Medical College of Wisconsin 95
Testing effectiveness (Phase 2)UnknownNCT02507479What this trial is testingThiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid MalignanciesWho this might be right forNon Hodgkin LymphomaHodgkin LymphomaChronic Lymphocytic Leukemia+1 more Sheba Medical Center 24
Early research (Phase 1)Looking for participantsNCT06060782What this trial is testingThiotepa, Cyclophosphamide, Clarithromycin and CytarabineWho this might be right forBurkitt LymphomaLymphoblastic Lymphoma, AdultAcute Lymphoblastic Leukemia, Adult Fifth Affiliated Hospital, Sun Yat-Sen University 28
Large-scale testing (Phase 3)Study completedNCT00354120What this trial is testingThymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic TransplantWho this might be right forAcute Myeloblastic LeukemiaLymphoblastic LeukemiaMyelodysplasia+3 more Gruppo Italiano Trapianto di Midollo Osseo 121
Not applicableNot Yet RecruitingNCT07644481What this trial is testingEfficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete RemissionWho this might be right forAML (Acute Myelogenous Leukemia)Allogeneic Hematopoietic Stem Cell Transplantation Recipient Institute of Hematology & Blood Diseases Hospital, China 30